Clinical Trials · NCT05659368
Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Ospedale San Raffaele
- Enrollment
- 10
- Start date
- Jan 2024
- Locations
- 1 site, Italy
- Primary endpoint
- changing in endogenous insulin production